Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
54,635,388
-
Shares change
-
+8,304,395
-
Total reported value, excl. options
-
$2,216,655,714
-
Value change
-
+$337,134,900
-
Number of buys
-
91
-
Number of sells
-
-77
-
Price
-
$40.57
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2017
201 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q1 2017.
HAEMONETICS CORP - Common Stock (HAE) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,635,388 shares
.
Largest 10 shareholders include BlackRock Inc. (6,289,728 shares), VANGUARD GROUP INC (4,694,325 shares), WELLINGTON MANAGEMENT GROUP LLP (4,192,350 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,470,891 shares), WELLS FARGO & COMPANY/MN (2,549,828 shares), VICTORY CAPITAL MANAGEMENT INC (2,394,135 shares), FULLER & THALER ASSET MANAGEMENT, INC. (2,209,450 shares), Neuberger Berman Group LLC (2,008,284 shares), DIMENSIONAL FUND ADVISORS LP (1,699,353 shares), and HealthCor Management, L.P. (1,600,000 shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.